Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma

被引:0
|
作者
Shinya Neri
Genichiro Ishii
Tetsuhiko Taira
Tomoyuki Hishida
Junji Yoshida
Mitsuyo Nishimura
Kanji Nagai
Atsushi Ochiai
机构
[1] National Cancer Center Hospital East,Pathology Division, Research Center for Innovative Oncology
[2] National Cancer Center Hospital East,Division of Thoracic Oncology
来源
关键词
Lung Adenocarcinoma; Metastatic Lesion; Metastatic Lymph Node; Metastatic Site; Lymphatic Endothelial Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3953 / 3962
页数:9
相关论文
共 50 条
  • [41] 18F-FDG uptake of N2 lymph nodes and primary tumor on PET: Clinical significance in stage IIIA N2 non-small-cell lung cancer
    Na, I.
    Byun, B.
    Kang, H.
    Cheon, G.
    Koh, J.
    Park, J.
    Baek, H.
    Lee, S.
    Ryoo, B.
    Lee, J.
    Yang, S.
    Yoo, H.
    Choe, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S288 - S288
  • [42] Postoperative Radiation Therapy (PORT) Is Associated With Better Survival in Non-Small Cell Lung Cancer With Involved N2 Lymph Nodes
    Mikell, J. L.
    Gillespie, T. W.
    Hall, W. A.
    Nickleach, D. C.
    Liu, Y.
    Lipscomb, J.
    Ramalingam, S. S.
    Rajpara, R. S.
    Force, S. D.
    Fernandez, F. G.
    Owonikoko, T. K.
    Pillai, R. N.
    Khuri, F. R.
    Jegadeesh, N. K.
    Curran, W. J.
    Higgins, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S18 - S18
  • [43] Clinical significance of 18F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer:: A retrospective study
    Na, Im Il
    Cheon, Gi Jeong
    Choe, Du Hwan
    Byun, Byung Hyun
    Kang, Hye Jin
    Koh, Jae Soo
    Park, Jong Ho
    Baek, Hee Jong
    Ryoo, Baek-Yeol
    Lee, Jae Cheol
    Yang, Sung Hyun
    LUNG CANCER, 2008, 60 (01) : 69 - 74
  • [44] Residual N2 or N3 disease after induction chemoradiation in stage III non small cell lung cancer predicts for distant recurrence
    DeYoung, C. M.
    Edelman, M.
    Buchner, E.
    Kwong, K.
    Gamliel, Z.
    Krasna, M.
    Schuetz, J.
    Suntharalingam, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S461 - S462
  • [45] ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy
    Yang, Xue
    Wang, Lili
    Jin, Xiangfeng
    Xu, Rongjian
    Yu, Zhuang
    Li, Hongmei
    Lu, Haijun
    An, Ning
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number
    Wang, Siwei
    Ma, Zhifei
    Yang, Xiangbao
    Wang, Yajing
    Xu, Youtao
    Xia, Wenjia
    Chen, Rui
    Qiu, Mantang
    Jiang, Feng
    Yin, Rong
    Xu, Lin
    Xu, Keping
    RADIATION ONCOLOGY, 2017, 12
  • [47] Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number
    Siwei Wang
    Zhifei Ma
    Xiangbao Yang
    Yajing Wang
    Youtao Xu
    Wenjia Xia
    Rui Chen
    Mantang Qiu
    Feng Jiang
    Rong Yin
    Lin Xu
    Keping Xu
    Radiation Oncology, 12
  • [48] Commentary: The Benefit of Surgery for Stage III N2 Positive Non-Small Cell Lung Cancer is Independent of Where the Okies Go
    Abbas, Abbas E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (01) : 309 - 310
  • [49] Analysis of factors related to N2-or N3-stage breast cancer associated with 1-2 positive sentinel lymph nodes in Chinese patients
    Luo, Ming
    Yuan, Huiming
    Long, Cheng
    Su, Ka
    Li, Fu
    Zeng, Jian
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2249 - 2258
  • [50] Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer
    Lin, Yen-Kuang
    Hsu, Han-Lin
    Lin, Wei-Cheng
    Chang, Jer-Hwa
    Chang, Yw-Chun
    Chang, Chia-Lun
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    ONCOTARGET, 2017, 8 (21) : 35280 - 35288